HLB Genex, Inc. (KOSDAQ:187420)
South Korea · Delayed Price · Currency is KRW 2,225.00
+25.00 (1.14%)
At close: Jun 10, 2026
HLB Genex Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 44,346 | 43,370 | 35,430 | 27,008 | 27,802 | 25,874 |
| 44,346 | 43,370 | 35,430 | 27,008 | 27,802 | 25,874 | |
Revenue Growth (YoY) | 13.68% | 22.41% | 31.18% | -2.85% | 7.45% | 37.85% |
Cost of Revenue | 28,536 | 28,332 | 21,129 | 19,677 | 17,586 | 16,043 |
Gross Profit | 15,810 | 15,038 | 14,301 | 7,331 | 10,215 | 9,831 |
Selling, General & Admin | 7,628 | 7,168 | 4,869 | 4,037 | 4,130 | 2,919 |
Research & Development | 5,980 | 5,903 | 10,271 | 11,608 | 11,681 | 10,413 |
Amortization of Goodwill & Intangibles | 60.24 | 38.34 | 44.52 | 44.81 | 44.5 | 42.49 |
Other Operating Expenses | - | - | - | 643.1 | 70.84 | 68.78 |
Operating Expenses | 14,329 | 13,763 | 16,147 | 16,795 | 16,440 | 13,665 |
Operating Income | 1,481 | 1,276 | -1,846 | -9,464 | -6,224 | -3,834 |
Interest Expense | -11,448 | -10,996 | -4,257 | -5,506 | -6,328 | -3,963 |
Interest & Investment Income | 1,202 | 1,335 | 521.64 | 1,090 | 1,009 | 431.41 |
Earnings From Equity Investments | -658.26 | -214.25 | - | - | - | - |
Currency Exchange Gain (Loss) | 350.17 | 392.89 | 383.92 | 92.88 | 220.13 | 142.47 |
Other Non Operating Income (Expenses) | 29,433 | 29,502 | -12,757 | 6,091 | 1,215 | -6,451 |
EBT Excluding Unusual Items | 20,359 | 21,296 | -17,955 | -7,696 | -10,108 | -13,674 |
Gain (Loss) on Sale of Investments | 2,475 | 2,475 | - | -2,047 | -1,572 | -619.8 |
Gain (Loss) on Sale of Assets | -236.94 | 117.84 | -96.38 | -211.99 | -7.43 | -108.57 |
Asset Writedown | - | -0.54 | -142.61 | -1,833 | - | -0.02 |
Other Unusual Items | 18.35 | 16.12 | 1,296 | 11,001 | 351.77 | - |
Pretax Income | 22,616 | 23,905 | -16,898 | -786.51 | -11,336 | -14,402 |
Income Tax Expense | 916.7 | 1,007 | 1,035 | -64.76 | 2,037 | -5,876 |
Earnings From Continuing Operations | 21,699 | 22,898 | -17,933 | -721.75 | -13,373 | -8,526 |
Minority Interest in Earnings | -285.74 | -306.39 | -895.34 | -2,228 | 405.12 | 1,710 |
Net Income | 21,414 | 22,591 | -18,828 | -2,950 | -12,968 | -6,817 |
Net Income to Common | 21,414 | 22,591 | -18,828 | -2,950 | -12,968 | -6,817 |
Shares Outstanding (Basic) | 29 | 29 | 24 | 23 | 23 | 22 |
Shares Outstanding (Diluted) | 49 | 48 | 24 | 23 | 23 | 22 |
Shares Change (YoY) | 93.73% | 105.88% | 4.10% | 0.44% | 0.30% | 2.01% |
EPS (Basic) | 733.07 | 775.35 | -800.00 | -130.50 | -576.16 | -303.76 |
EPS (Diluted) | 580.81 | 606.00 | -800.00 | -130.50 | -576.16 | -304.00 |
Free Cash Flow | 2,925 | 2,682 | 2,221 | -6,028 | -8,732 | -11,102 |
Free Cash Flow Per Share | 60.28 | 55.34 | 94.39 | -266.63 | -387.97 | -494.72 |
Gross Margin | 35.65% | 34.67% | 40.36% | 27.14% | 36.74% | 38.00% |
Operating Margin | 3.34% | 2.94% | -5.21% | -35.04% | -22.39% | -14.82% |
Profit Margin | 48.29% | 52.09% | -53.14% | -10.92% | -46.64% | -26.35% |
Free Cash Flow Margin | 6.60% | 6.18% | 6.27% | -22.32% | -31.41% | -42.91% |
EBITDA | 5,947 | 5,746 | 2,640 | -4,824 | -1,782 | -95.46 |
EBITDA Margin | 13.41% | 13.25% | 7.45% | -17.86% | -6.41% | -0.37% |
D&A For EBITDA | 4,467 | 4,471 | 4,487 | 4,640 | 4,442 | 3,739 |
EBIT | 1,481 | 1,276 | -1,846 | -9,464 | -6,224 | -3,834 |
EBIT Margin | 3.34% | 2.94% | -5.21% | -35.04% | -22.39% | -14.82% |
Effective Tax Rate | 4.05% | 4.21% | - | - | - | - |
Advertising Expenses | - | 180.66 | 146.49 | 59.82 | 86.97 | 26.09 |